Shehnaaz Suliman

Shehnaaz Suliman is currently the Chief Executive Officer & Director at ReCode Therapeutics, Inc. She also serves as the Chairman at Executive Women in Bio.
In addition, she holds positions as an Independent Director at Ultragenyx Pharmaceutical, Inc. and 10X Genomics, Inc. Previously, she worked as a Director at Parvus Therapeutics, Inc. from 2017 to 2019.
Prior to that, she was the Vice President & Head-Global Therapeutic at Roche Holding AG from 2015 to 2017.
She also served as the Senior VP-Corporate Development & Strategy at Theravance Biopharma, Inc. from 2017 to 2019.
From 2021 to 2022, she was the Chief Operating & Business Officer at Alector, Inc. Dr. Suliman obtained a graduate degree and an MBA from the University of Oxford.
She also holds an undergraduate degree and a doctorate from the University of Cape Town.
Additionally, she earned an MBA from Saïd Business School.